Sysmex (OTCMKTS:SSMXY) Reaches New 1-Year High – Here’s Why

Sysmex Corporation ADR (OTCMKTS:SSMXY) shares reached a new 52-week high during mid-day trading on Thursday. The stock traded as high as $13.01 and last traded at $12.41, with a volume of 1,624 shares changing hands. The stock had previously closed at $11.82.

Wall Street Analyst Weigh In

Separately, Zacks Research raised Sysmex from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 18th. Two investment analysts have rated the stock with a Hold rating. According to data from MarketBeat, Sysmex presently has an average rating of “Hold”.

Sysmex Stock Up 0.3%

The firm has a market cap of $7.56 billion, a price-to-earnings ratio of 29.60 and a beta of 1.18. The company has a debt-to-equity ratio of 0.23, a current ratio of 3.40 and a quick ratio of 2.53. The stock has a 50-day moving average of $11.90 and a 200-day moving average of $10.14.

Sysmex (OTCMKTS:SSMXY) last posted its quarterly earnings data on Friday, August 7th. The company reported $0.09 EPS for the quarter, topping analysts’ consensus estimates of $0.07 by $0.02. The firm had revenue of $825.85 million for the quarter, compared to analyst estimates of $741.67 million. Sysmex had a return on equity of 8.01% and a net margin of 7.62%. Sysmex has set its FY 2026 guidance at 0.382-0.382 EPS. Sell-side analysts predict that Sysmex Corporation ADR will post 0.41 EPS for the current fiscal year.

Sysmex Company Profile

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and distributes clinical laboratory instruments, reagents and related information systems. Its products are used by hospitals, diagnostic laboratories and other healthcare providers to support the analysis of blood, urine and other biological samples.

The company is best known for its hematology analyzers, which help laboratories evaluate blood cells and identify conditions such as anemia and leukemia.